GLORIA

GEOMAR Library Ocean Research Information Access

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    In: The Journal of Infectious Diseases, Oxford University Press (OUP), Vol. 216, No. 1 ( 2017-07-01), p. 92-96
    Type of Medium: Online Resource
    ISSN: 0022-1899 , 1537-6613
    RVK:
    Language: English
    Publisher: Oxford University Press (OUP)
    Publication Date: 2017
    detail.hit.zdb_id: 1473843-0
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 2
    In: Cancer Research, American Association for Cancer Research (AACR), Vol. 71, No. 8_Supplement ( 2011-04-15), p. 950-950
    Abstract: Objective: Merkel cell polyomavirus (MCV) DNA has been reported previously in 0-25% of squamous cell carcinomas (SCC) occurring in immunocompetent individuals. No studies have investigated MCV seroreactivity in individuals with SCC. We conducted a clinic-based case-control study to investigate the association between MCV seroreactivity and SCC, overall and stratified by MCV DNA status of the SCC tumor tissue. Methods: Patients with histologically-confirmed cutaneous SCC (n=173) were recruited from a university dermatology clinic. Controls were patients undergoing skin cancer screening exams who screened negative for and had no history of skin or other cancers (n=300). Levels of antibodies against capsid antigens for MCV and other polyomavirus controls (JC virus (JCV) and KI virus (KIV)) were determined by fluorescent bead-based multiplex serology. Fresh-frozen tumor tissues were obtained from 145 SCC cases, and DNA from six polyomaviruses (MCV, JCV, KIV, WU virus (WUV), BK virus (BKV) and simian virus 40 (SV40)) was measured using multiplexed PCR. Polyomavirus seropositivity, based on binary cutpoints, and quartiles of seroreactivity, based on the control distribution, were compared between SCC cases and controls, overall and stratified by the presence or absence of MCV DNA in SCC tumor tissues. Associations were estimated by calculating odds ratios (OR) and 95% confidence intervals (CI) using logistic regression to adjust for age, sex, and skin reaction to the sun. Results: MCV seropositivity was associated with a statistically significant increased risk of SCC (OR=1.80, 95% CI=1.03-3.12), whereas no association was observed for JCV (OR=1.17, 95% CI=0.72-1.92) or KIV (OR=0.88, 95% CI=0.37-2.09) seropositivity. MCV DNA was detected in 55 (38%) of SCC tumor tissues, whereas all tissues were negative for DNA from the other five polyomaviruses. Using controls as the reference group, MCV DNA-positive SCC cases were three times as likely to be MCV seropositive (OR=3.15, 95% CI=1.11-8.92) and almost six times as likely to have MCV antibody levels in the fourth versus first quartile (OR=5.94, 95% CI=1.79-19.74, ptrend=0.001). No associations were observed between MCV seropositivity and MCV DNA-negative SCC (OR=1.40, 95% CI=0.78-2.77) or between JCV or KIV seropositivity and MCV DNA-negative or DNA-positive SCC. Conclusion: SCC patients were significantly more likely than controls to exhibit MCV seroreactivity, particularly if they had MCV DNA in their SCC tumor tissue. This association was specific to MCV, with no associations observed for the other polyomaviruses studied. These results suggest that past exposure to MCV may be a risk factor for SCC in immunocompetent individuals. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 102nd Annual Meeting of the American Association for Cancer Research; 2011 Apr 2-6; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2011;71(8 Suppl):Abstract nr 950. doi:10.1158/1538-7445.AM2011-950
    Type of Medium: Online Resource
    ISSN: 0008-5472 , 1538-7445
    RVK:
    RVK:
    Language: English
    Publisher: American Association for Cancer Research (AACR)
    Publication Date: 2011
    detail.hit.zdb_id: 2036785-5
    detail.hit.zdb_id: 1432-1
    detail.hit.zdb_id: 410466-3
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 3
    In: International Journal of Cancer, Wiley, Vol. 123, No. 10 ( 2008-11-15), p. 2337-2342
    Type of Medium: Online Resource
    ISSN: 0020-7136 , 1097-0215
    URL: Issue
    RVK:
    Language: English
    Publisher: Wiley
    Publication Date: 2008
    detail.hit.zdb_id: 218257-9
    detail.hit.zdb_id: 1474822-8
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 4
    In: International Journal of Cancer, Wiley, Vol. 134, No. 9 ( 2014-05), p. 2231-2244
    Abstract: What's new Some HPVs contribute to cervical cancer, but other types, called genus beta HPVs, commonly infect the skin and are associated with squamous cell carcinoma. In this study, the authors investigated the association between genus‐beta HPV DNA found in plucked eyebrow hairs and the presence of SCC, as well as the presence of genus‐beta HPV DNA in the tumor tissue. They found that the viruses were found in eyebrow hairs more often in those with cancer than those without, suggesting that the virus plays a role in cancer development, and could make a good therapeutic target.
    Type of Medium: Online Resource
    ISSN: 0020-7136 , 1097-0215
    URL: Issue
    RVK:
    Language: English
    Publisher: Wiley
    Publication Date: 2014
    detail.hit.zdb_id: 218257-9
    detail.hit.zdb_id: 1474822-8
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 5
    In: Cancer Research, American Association for Cancer Research (AACR), Vol. 81, No. 17 ( 2021-09-01), p. 4628-4638
    Abstract: Cutaneous human papillomavirus (cuHPV) infections may be novel targets for skin cancer prevention and treatment, but critical information regarding the development of virus-positive skin cancers following cuHPV infection has been lacking. In this study, baseline cuHPV infection was measured by serology and viral DNA detection in eyebrow hairs (EBH) and forearm skin swabs (SSW) among 1,008 individuals undergoing routine skin cancer screening exams and followed for incidence of basal cell carcinoma (BCC) and cutaneous squamous cell carcinoma (cuSCC). Baseline β-HPV detection, particularly in SSW, significantly predicted cuSCC (HR = 4.32; 95% confidence interval, 1.00–18.66), whereas serologic evidence of past β-HPV infection was not associated with cuSCC. Less than 5% of baseline β-HPV types detected in SSW were present in subsequent cuSCC tumors, and cuHPV detected in SSW with higher mean fluorescence intensity values were more likely to be present in cuSCC compared with those with lower levels (P & lt; 0.001). β-HPV-positive cuSCC occurred more often in areas of highly sun-damaged skin than did β-HPV-negative cuSCC. Overall, no clear patterns were observed between baseline β-HPV detection and subsequent development of BCC, or between baseline γ-HPV detection and either cuSCC or BCC. Collectively, these results demonstrate that β-HPV detection in SSW is a significant predictor of cuSCC risk, although evidence suggests only a small subset of cuSCC is etiologically linked to β-HPV infection. Significance: β-HPV positivity may be a useful biomarker for identifying individuals who could benefit from increased screening or novel cutaneous squamous cell carcinoma prevention strategies.
    Type of Medium: Online Resource
    ISSN: 0008-5472 , 1538-7445
    RVK:
    RVK:
    Language: English
    Publisher: American Association for Cancer Research (AACR)
    Publication Date: 2021
    detail.hit.zdb_id: 2036785-5
    detail.hit.zdb_id: 1432-1
    detail.hit.zdb_id: 410466-3
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 6
    In: Cancer Research, American Association for Cancer Research (AACR), Vol. 76, No. 14_Supplement ( 2016-07-15), p. 3439-3439
    Abstract: Background: We previously reported that cutaneous human papillomavirus (HPV) infection was associated with significantly increased risk of cutaneous squamous cell carcinoma (SCC), while longer telomeres were associated with significantly reduced risk of SCC. We conducted further research to evaluate the interaction between cutaneous HPV and telomere length in association with SCC. Methods: Previously, a clinic based case-control (173 SCC cases and 300 controls) study was conducted, between 2007-2008, at the University of South Florida and Moffitt Cancer Center. HPV seropositivity (33 types) and DNA positivity (25 beta-HPV types) in eyebrow hairs (EB) and SCC tumors were measured using multiplex assays. Using quantitative PCR, relative telomere length was measured in peripheral blood leukocytes by determining the ratio of telomere repeat copy number to a single-copy gene copy number for each sample. For the present analyses, subjects with available data on telomere length and a) HPV serology (135 cases and 201 controls), b) HPV DNA in EB (130 SCC cases and 195 controls) and c) HPV DNA in SCC tumors (117 cases), were included. Association between telomere length and SCC was examined after stratification by HPV serostatus and HPV DNA status in EB, and odds ratios (ORs) and 95% confidence intervals (CIs) were estimated using logistic regression, adjusting for age and gender. Results: Telomere length did not differ significantly between beta-HPV seronegative (mean = 1.16, standard deviation (SD) = 0.57) and seropositive controls [mean (SD) = 1.24(0.75), P value = 0.56], or by tumor HPV DNA status (P value = 0.93). Longer telomere length was associated with significantly reduced risk of SCC among subjects seronegative to all HPV types or seropositive to a single beta1 HPV type (OR = 0.01, 95% CI = 0.001-0.10), while no association was observed among those seropositive to & gt;1 beta1 HPV types (OR = 1.01, 95% CI = 0.95-1.07, Pinteraction = & lt;0.0001). A significant interaction (Pinteraction = 0.0004) was also observed between telomere length and DNA positivity for & gt; = 1 beta-HPV types in EB in association with SCC (OREB DNA negative = 0.003, 95% CI = & lt;0.001-0.09; OREB DNA positive = 1.02, 95% CI = 0.98-1.06). Further, longer telomere length was associated with 62% (OR = 0.38, 95% CI = 0.19-0.75, Pinteraction = 0.004) and 55% (OR = 0.45, 95% CI = 0.23-0.90, Pinteraction = 0.01) reduced risk of SCC among subjects DNA negative for all beta-HPV types or positive for a single beta1 or beta2 type, respectively, while no associations were observed among those with EB DNA positivity for & gt;1 beta1 or beta2 types (OR = 1.02, 95% CI = 0.98-1.07 for both groups). In summary, multiple beta-HPV infections showed significant statistical interaction with telomere length in association with SCC. Conclusion: Presence of cutaneous HPV infection may attenuate the protective effect of longer telomeres on the risk of SCC. Citation Format: Shalaka S. Hampras, Michael Pawlita, Massimo Tommasino, Jong Park, Pearlie K. Burnette, Neil A. Fenske, Basil A. Cherpelis, Dana E. Rollison. Interaction between cutaneous human papillomavirus infection and telomere length in association with cutaneous squamous cell carcinoma. [abstract] . In: Proceedings of the 107th Annual Meeting of the American Association for Cancer Research; 2016 Apr 16-20; New Orleans, LA. Philadelphia (PA): AACR; Cancer Res 2016;76(14 Suppl):Abstract nr 3439.
    Type of Medium: Online Resource
    ISSN: 0008-5472 , 1538-7445
    RVK:
    RVK:
    Language: English
    Publisher: American Association for Cancer Research (AACR)
    Publication Date: 2016
    detail.hit.zdb_id: 2036785-5
    detail.hit.zdb_id: 1432-1
    detail.hit.zdb_id: 410466-3
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 7
    Online Resource
    Online Resource
    Oxford University Press (OUP) ; 2015
    In:  The Journal of Infectious Diseases Vol. 211, No. 9 ( 2015-05), p. 1437-1446
    In: The Journal of Infectious Diseases, Oxford University Press (OUP), Vol. 211, No. 9 ( 2015-05), p. 1437-1446
    Type of Medium: Online Resource
    ISSN: 0022-1899 , 1537-6613
    RVK:
    Language: English
    Publisher: Oxford University Press (OUP)
    Publication Date: 2015
    detail.hit.zdb_id: 1473843-0
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 8
    In: International Journal of Cancer, Wiley, Vol. 148, No. 2 ( 2021-01-15), p. 448-458
    Abstract: What's new? Infection with cutaneous human papillomavirus (HPV) or human polyomavirus (HPyV), may influence risk of keratinocyte carcinoma, but it's not known what role ultraviolet radiation (UVR) plays. Here, the authors undertook the first epidemiological study to probe the association between these viral infections and UVR exposure. They used a spectrophotometer to quantitatively measure UVR exposure, and they tested for biomarkers of 24 different HPV types and 4 types of HPyV. People with the highest levels of UVR exposure were the most likely to test positive for beta‐HPV, in blood tests, in eyebrow hairs and in skin swabs.
    Type of Medium: Online Resource
    ISSN: 0020-7136 , 1097-0215
    URL: Issue
    RVK:
    Language: English
    Publisher: Wiley
    Publication Date: 2021
    detail.hit.zdb_id: 218257-9
    detail.hit.zdb_id: 1474822-8
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 9
    In: Cancer Research, American Association for Cancer Research (AACR), Vol. 73, No. 8_Supplement ( 2013-04-15), p. 4835-4835
    Abstract: Objective: Cutaneous human papillomavirus (HPV) antibodies and/or DNA in eyebrow hairs have been associated with cutaneous squamous cell carcinoma (SCC) in several case-control studies, including one from New Hampshire and ours from Florida. In the New Hampshire study, a single nucleotide polyomorphism (SNP) in the EVER2 gene (rs72080422) was associated with both SCC and cutaneous HPV seropositivity among controls (Patel et al Int J Cancer, 2008). Additional genetic variants in the EVER1/2 region of chromosome 17q25 have since been identified and shown to be associated with cervical cancer susceptibility (Castro et al Int J Cancer, 2011). We investigated the identical EVER1/2 variants in association with multiple markers of cutaneous HPV infection, including HPV seropositivity, and HPV DNA in eyebrow hairs and SCC tumor tissues. Methods: Patients with histologically-confirmed cutaneous SCC (n=142) were recruited from a university dermatology clinic in Tampa, FL. Controls were patients undergoing skin cancer screening exams who screened negative for skin cancer and reported no history of any type of cancer (n=265). Levels of antibodies against capsid antigens for 15 cutaneous HPV types in genus beta were determined by fluorescent bead-based multiplex serology. DNA for 25 beta-HPV types was measured in eyebrow hairs from cases and controls, and in fresh-frozen tumor tissues from 119 SCC cases using multiplex PCR. Twenty-one SNPs in in the EVER1/2 region of chromosome 17q25 were measured from eyebrow hair DNA, including rs7208422. Associations between EVER1/2 SNPs and SCC, and between EVER1/2 SNPs and HPV serostatus or DNA status, were estimated by odds ratios (OR) and 95% confidence intervals (CI) calculated using logistic regression with adjustment for age and sex. Results: None of the 21 SNPs in the EVER1/2 region were associated with SCC, including rs7208422 in EVER2, for which the TT genotype was observed in 23% of cases and 22% of controls (vs. AA: OR=0.99, 95% CI=0.52-1.90). Seropositivity for any beta-HPV type was not associated with any of the EVER1/2 SNPs among the cases or the controls, nor with seropositivity for HPV types 5 and/or 8 specifically. Beta-HPV DNA in eyebrow hairs was associated with two SNPs among the controls only (rs2290907, AG vs. AA: OR= 2.96, 95% CI=1.37-6.40; rs16970829, AG vs. AA: OR=12.8, 95% CI=1.71-95.90). Among the cases, beta-HPV DNA in tumor tissue was associated with rs7217374 (AG vs AG: OR=3.65, 95% CI=1.42-9.36; AA vs GG: OR=2.02, 95% CI=0.71-5.79), but not with any of the other 20 SNPs. Conclusion: In this small case-control study, genetic variation in the EVER1/2 region was not associated with SCC, and none of the 21 SNPs measured were consistently associated with different biomarkers of beta-HPV infection among cases or controls. Citation Format: Dana E. Rollison, Michelle R. Iannacone, Jane L. Messina, Neil A. Fenske, Basil S. Cherpelis, Vernon K. Sondak, Richard G. Roetzheim, Tarik Gheit, Massimo Tommasino, Markus Schmitt, Michael Pawlita. Genetic variation in EVER1/EVER2 and beta human papillomavirus infection in cutaneous squamous cell carcinoma. [abstract]. In: Proceedings of the 104th Annual Meeting of the American Association for Cancer Research; 2013 Apr 6-10; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2013;73(8 Suppl):Abstract nr 4835. doi:10.1158/1538-7445.AM2013-4835
    Type of Medium: Online Resource
    ISSN: 0008-5472 , 1538-7445
    RVK:
    RVK:
    Language: English
    Publisher: American Association for Cancer Research (AACR)
    Publication Date: 2013
    detail.hit.zdb_id: 2036785-5
    detail.hit.zdb_id: 1432-1
    detail.hit.zdb_id: 410466-3
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...